Exclusive Summary

• Clozapine is a WHO Essential Medicine and the universally recognized gold standard for Treatment-Resistant Schizophrenia (TRS), serving a rigid global demand of up to 8 million patients.
• The 25mg low-dose specification perfectly aligns with the strict clinical requirement of 'low starting dose and slow titration' to minimize severe side effects, acting as a foundational dosage form.
• Supported by internationally compliant CTD documentation, it enables rapid local registration and quick market penetration for overseas distributors.
• Outstanding cost-effectiveness derived from Chinese manufacturing provides distribution partners with maximal profit margins and a vital competitive edge in lucrative public health tenders.